XOMA Corp (XOMA)
25.26
-0.18
(-0.71%)
USD |
NASDAQ |
May 03, 12:58
XOMA Cash from Financing (Quarterly): 124.49M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 124.49M |
| September 30, 2023 | -1.368M |
| June 30, 2023 | -1.165M |
| March 31, 2023 | -1.368M |
| December 31, 2022 | -1.322M |
| September 30, 2022 | -1.26M |
| June 30, 2022 | -1.134M |
| March 31, 2022 | -0.735M |
| December 31, 2021 | -1.439M |
| September 30, 2021 | -1.536M |
| June 30, 2021 | 17.81M |
| March 31, 2021 | -2.00M |
| December 31, 2020 | 23.16M |
| September 30, 2020 | -1.321M |
| June 30, 2020 | -0.951M |
| March 31, 2020 | -1.096M |
| December 31, 2019 | 21.09M |
| September 30, 2019 | 6.618M |
| June 30, 2019 | 2.984M |
| March 31, 2019 | -0.201M |
| December 31, 2018 | 20.06M |
| September 30, 2018 | 7.493M |
| June 30, 2018 | 0.071M |
| March 31, 2018 | 2.316M |
| December 31, 2017 | 0.921M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.446M |
| June 30, 2017 | 0.02M |
| March 31, 2017 | 7.871M |
| December 31, 2016 | -1.846M |
| September 30, 2016 | -1.813M |
| June 30, 2016 | 0.016M |
| March 31, 2016 | -3.299M |
| December 31, 2015 | 0.08M |
| September 30, 2015 | 0.149M |
| June 30, 2015 | -0.002M |
| March 31, 2015 | 13.57M |
| December 31, 2014 | 36.88M |
| September 30, 2014 | -0.732M |
| June 30, 2014 | -0.881M |
| March 31, 2014 | 0.296M |
| December 31, 2013 | 55.08M |
| September 30, 2013 | 29.09M |
| June 30, 2013 | -0.84M |
| March 31, 2013 | 0.06M |
| December 31, 2012 | 37.86M |
| September 30, 2012 | 3.969M |
| June 30, 2012 | -0.815M |
| March 31, 2012 | 38.77M |
| December 31, 2011 | 11.44M |
| September 30, 2011 | 2.525M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.00M
Minimum
Mar 2021
124.49M
Maximum
Dec 2023
9.446M
Average
-1.134M
Median
Jun 2022
Cash from Financing (Quarterly) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | 0.00 |
| Societal CDMO Inc (DELISTED) | -0.854M |
| Corcept Therapeutics Inc | 0.766M |
| Sarepta Therapeutics Inc | 22.14M |
| AnaptysBio Inc | -5.159M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.927M |
| Cash from Investing (Quarterly) | 5.511M |
| Free Cash Flow | -18.16M |
| Free Cash Flow Per Share (Quarterly) | -0.3419 |
| Free Cash Flow to Equity (Quarterly) | -127.99M |
| Free Cash Flow Yield | -6.27% |